BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 197 filers reported holding BLUEBIRD BIO INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $209,000 | -11.4% | 50,497 | +3.6% | 0.03% | +3.7% |
Q1 2022 | $236,000 | -4.1% | 48,724 | +97.8% | 0.03% | -3.6% |
Q4 2021 | $246,000 | +1.7% | 24,639 | +94.4% | 0.03% | -9.7% |
Q3 2021 | $242,000 | – | 12,673 | +253360.0% | 0.03% | – |
Q1 2020 | $0 | -100.0% | 5 | -98.4% | 0.00% | -100.0% |
Q4 2017 | $57,000 | – | 321 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |